BOSTON SCIENTIFIC CORP (BSX.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:BSX • US1011371077
78 EUR
+0.6 (+0.78%)
Last: Jan 30, 2026, 07:00 PM
BSX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. BSX has an excellent profitability rating, but there are some minor concerns on its financial health. BSX shows excellent growth, but is valued quite expensive already. These ratings could make BSX a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- BSX had positive earnings in the past year.
- BSX had a positive operating cash flow in the past year.
- BSX had positive earnings in 4 of the past 5 years.
- BSX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of 6.54%, BSX is doing good in the industry, outperforming 74.60% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 11.93%, BSX is in the better half of the industry, outperforming 73.02% of the companies in the same industry.
- BSX has a better Return On Invested Capital (8.09%) than 69.84% of its industry peers.
- BSX had an Average Return On Invested Capital over the past 3 years of 6.59%. This is below the industry average of 9.95%.
- The last Return On Invested Capital (8.09%) for BSX is above the 3 year average (6.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.54% | ||
| ROE | 11.93% | ||
| ROIC | 8.09% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
1.3 Margins
- BSX has a Profit Margin of 14.42%. This is amongst the best in the industry. BSX outperforms 84.13% of its industry peers.
- BSX's Profit Margin has declined in the last couple of years.
- The Operating Margin of BSX (19.40%) is better than 82.54% of its industry peers.
- In the last couple of years the Operating Margin of BSX has remained more or less at the same level.
- The Gross Margin of BSX (68.57%) is better than 77.78% of its industry peers.
- BSX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.4% | ||
| PM (TTM) | 14.42% | ||
| GM | 68.57% |
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BSX is destroying value.
- Compared to 1 year ago, BSX has more shares outstanding
- The number of shares outstanding for BSX has been increased compared to 5 years ago.
- BSX has a worse debt/assets ratio than last year.
2.2 Solvency
- BSX has an Altman-Z score of 5.25. This indicates that BSX is financially healthy and has little risk of bankruptcy at the moment.
- BSX has a better Altman-Z score (5.25) than 85.71% of its industry peers.
- BSX has a debt to FCF ratio of 3.03. This is a good value and a sign of high solvency as BSX would need 3.03 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 3.03, BSX is doing good in the industry, outperforming 73.02% of the companies in the same industry.
- A Debt/Equity ratio of 0.48 indicates that BSX is not too dependend on debt financing.
- BSX has a Debt to Equity ratio of 0.48. This is comparable to the rest of the industry: BSX outperforms 49.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 3.03 | ||
| Altman-Z | 5.25 |
ROIC/WACC0.82
WACC9.82%
2.3 Liquidity
- BSX has a Current Ratio of 1.51. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BSX (1.51) is comparable to the rest of the industry.
- BSX has a Quick Ratio of 1.51. This is a bad value and indicates that BSX is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.96, BSX is in line with its industry, outperforming 42.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
- BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
- BSX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.56% yearly.
- BSX shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.62%.
- BSX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.30% yearly.
EPS 1Y (TTM)25%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%19.05%
Revenue 1Y (TTM)21.62%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.34%
3.2 Future
- The Earnings Per Share is expected to grow by 15.06% on average over the next years. This is quite good.
- Based on estimates for the next years, BSX will show a quite strong growth in Revenue. The Revenue will grow by 12.60% on average per year.
EPS Next Y22.12%
EPS Next 2Y18.13%
EPS Next 3Y16.37%
EPS Next 5Y15.06%
Revenue Next Year20.92%
Revenue Next 2Y16.08%
Revenue Next 3Y14.31%
Revenue Next 5Y12.6%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 31.71, BSX can be considered very expensive at the moment.
- BSX's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 28.30. BSX is around the same levels.
- Based on the Price/Forward Earnings ratio of 26.65, the valuation of BSX can be described as expensive.
- BSX's Price/Forward Earnings is on the same level as the industry average.
- BSX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.71 | ||
| Fwd PE | 26.65 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BSX indicates a slightly more expensive valuation: BSX is more expensive than 61.90% of the companies listed in the same industry.
- BSX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.2 | ||
| EV/EBITDA | 28.92 |
4.3 Compensation for Growth
- BSX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of BSX may justify a higher PE ratio.
- A more expensive valuation may be justified as BSX's earnings are expected to grow with 16.37% in the coming years.
PEG (NY)1.43
PEG (5Y)3.32
EPS Next 2Y18.13%
EPS Next 3Y16.37%
5. Dividend
5.1 Amount
- No dividends for BSX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BOSTON SCIENTIFIC CORP / BSX.DE FAQ
What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (BSX.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BSX.DE.
What is the valuation status for BSX stock?
ChartMill assigns a valuation rating of 3 / 10 to BOSTON SCIENTIFIC CORP (BSX.DE). This can be considered as Overvalued.
How profitable is BOSTON SCIENTIFIC CORP (BSX.DE) stock?
BOSTON SCIENTIFIC CORP (BSX.DE) has a profitability rating of 7 / 10.
What is the valuation of BOSTON SCIENTIFIC CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (BSX.DE) is 31.71 and the Price/Book (PB) ratio is 5.92.
Can you provide the expected EPS growth for BSX stock?
The Earnings per Share (EPS) of BOSTON SCIENTIFIC CORP (BSX.DE) is expected to grow by 22.12% in the next year.